Caroverine
Trade name: spadon
Small moleculeexperimental
Caroverine is an antispasmodic drug used in Austria and Switzerland to relieve spasms in smooth muscles, as well as to treat cerebrovascular diseases and tinnitus. — Wikipedia
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Jan 1, 2011 (NCT01174979)
Timeline
2010s
- Jan 1, 2011
Earliest Phase 3 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Glutamate [NMDA] receptor subunit 3AINHIBITOR
GRIN3A inhibitor
Chemistry & pharmacology
Loading structure…
SMILES
CCN(CC)CCn1c(=O)c(Cc2ccc(OC)cc2)nc2ccccc21- Mol. weight
- 365.48 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaCaroverine ↗
- ChEMBLCHEMBL1729803 ↗
Also known as
- caroverin
- caroverin
- caroverine
- caroverine
- caroverine
- caroverine
- caroverine
- spadon
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01174979 | Phase 3 | Jan 1, 2011 | Landeskrankenhaus Feldkirch, Phafag AG |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Landeskrankenhaus Feldkirch | Academic/Hospital | 1 | 0 | 1 | 2011 |
| Phafag AG | For profit | 1 | 1 | 1 | 2011 |
2 organizations
Page 1 / 1